| |
| |
|
| Insider
Information: |
Gano Kyle |
| Relationship: |
Chief Business Develop... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
135,166 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,687,823 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
135,166 |
|
|
| Total
Value |
$17,687,823 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Business Develop... |
2024-02-13 |
135,166 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2020-02-05 |
4 |
AS |
$103.01 |
$380,262 |
D/D |
(3,690) |
89,614 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2020-02-07 |
4 |
AS |
$103.33 |
$167,710 |
D/D |
(1,623) |
91,975 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2023-02-08 |
4 |
AS |
$103.99 |
$101,910 |
D/D |
(980) |
128,096 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2023-02-06 |
4 |
AS |
$105.64 |
$169,028 |
D/D |
(1,600) |
114,257 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2023-08-21 |
4 |
AS |
$107.41 |
$228,993 |
D/D |
(2,132) |
130,250 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2023-01-31 |
4 |
AS |
$109.98 |
$169,486 |
D/D |
(1,541) |
112,820 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2021-02-05 |
4 |
AS |
$113.77 |
$305,184 |
D/D |
(2,677) |
100,439 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2018-08-01 |
4 |
AS |
$115.00 |
$3,250,590 |
D/D |
(28,266) |
78,742 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2021-02-08 |
4 |
AS |
$116.83 |
$431,518 |
D/D |
(3,693) |
104,768 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2020-08-05 |
4 |
AS |
$118.87 |
$268,286 |
D/D |
(2,257) |
95,997 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2024-01-02 |
4 |
AS |
$131.44 |
$9,860,194 |
D/D |
(75,000) |
130,250 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2024-02-13 |
4 |
AS |
$132.89 |
$179,674 |
D/D |
(1,352) |
135,166 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2024-02-08 |
4 |
AS |
$134.20 |
$131,519 |
D/D |
(980) |
133,952 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2024-01-31 |
4 |
AS |
$140.70 |
$216,813 |
D/D |
(1,541) |
131,635 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Business Development Off |
• – – |
2024-02-06 |
4 |
AS |
$142.20 |
$227,522 |
D/D |
(1,600) |
133,072 |
0 |
% |
|
65 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
